Actively Recruiting
The Research Value of Multi-omics and Multi-modal Information in the Diagnosis and Treatment of Urinary System Tumors
Led by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Updated on 2024-07-08
100
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Obtain puncture or surgically removed tumor tissue samples from patients with urinary tract tumors and perform RNA-sequencing, Single-cell RNA-sequence, Spatial Transcriptomics, Proteomics, and Intratumoral Microbiome.
CONDITIONS
Official Title
The Research Value of Multi-omics and Multi-modal Information in the Diagnosis and Treatment of Urinary System Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients treated for bladder cancer, kidney cancer, or prostate cancer at Wuhan Union Hospital from January 2024 to January 2026
- Age over 18 years
- Evidence of tumor from urinalysis, urine exfoliated cells, ultrasound, CT, or MRI
- Diagnosis confirmed by tissue biopsy pathological examination
You will not qualify if you...
- Poor image quality
- Incomplete clinical data or lost to follow-up
- Another primary malignant tumor besides urinary tract tumor
- Unclear pathological diagnosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Union Hospital，Tongji Medical College，Huazhong University of Science and Technology
Wuhan, Hubei, China, 430000
Actively Recruiting
Research Team
L
Lian Yang
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here